Susan M O'Brien (Susan O'Brien, Susan O'brien)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 16

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Prognostic Factors

Acute Lymphoblastic Leukemia

Top Venues

American journal of hematology

European journal of haematology

Clinical cancer research : an official journal of the American Association for Cancer Research

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Benjamin J Lee, Piyanuch Kongtim, Jean Doh, Shawn P Griffin, Alexandre Chan, Susan M O'Brien, Stefan O Ciurea, Deepa Jeyakumar
Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice change. European journal of haematology (2023)
Jennifer A Woyach, Paolo Ghia, John C Byrd, Inhye E Ahn, Carol Moreno, Susan M O'Brien, Daniel M Jones, Leo W K Cheung, Elizabeth Chong, Kevin Kwei, James P Dean, Danelle F James, Adrian Wiestner
B-cell receptor pathway mutations are infrequent in patients with chronic lymphocytic leukemia on continuous ibrutinib therapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Benjamin J Lee, Piyanuch Kongtim, Jean Doh, Shawn P Griffin, Alexandre Chan, Susan M O'Brien, Stefan O Ciurea, Deepa Jeyakumar
Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice change. European journal of haematology (2023)
Benjamin J Lee, Shawn P Griffin, Jean Doh, Alexandre Chan, Stefan O Ciurea, Deepa Jeyakumar, Angela G Fleischman, Kiran Naqvi, Nicholas R Pannunzio, Susan M O'Brien, Piyanuch Kongtim
HyperCVAD versus pegaspargase-containing regimens for Hispanic adults with newly diagnosed B-cell acute lymphoblastic leukemia. European journal of haematology (2023)
Benjamin J Lee, Shawn P Griffin, Jean Doh, Piyanuch Kongtim, Alexandre Chan, Susan M O'Brien, Deepa Jeyakumar, Stefan O Ciurea
Timing of intrathecal chemotherapy and blinatumomab impacts neurotoxicity in acute lymphoblastic leukemia. American journal of hematology (2023)
Benjamin J Lee, Piyanuch Kongtim, Jean Doh, Shawn P Griffin, Alexandre Chan, Susan M O'Brien, Stefan O Ciurea, Deepa Jeyakumar
Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice change. European journal of haematology (2023)
Paul M Barr, Alessandra Tedeschi, William G Wierda, John N Allan, Paolo Ghia, Daniele Vallisa, Ryan Jacobs, Susan M O'Brien, Andrew P Grigg, Patricia Walker, Cathy Zhou, Joi Ninomoto, Gabriel Krigsfeld, Constantine S Tam
Effective Tumor Debulking with Ibrutinib Before Initiation of Venetoclax: Results from the CAPTIVATE Minimal Residual Disease and Fixed-Duration Cohorts. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (20) (2022)
Tait D Shanafelt, Xin Victoria Wang, Curtis A Hanson, Elisabeth M Paietta, Susan M O'Brien, Jacqueline Barrientos, Diane F Jelinek, Esteban Braggio, Jose F Leis, Cong Christine Zhang, Steven E Coutre, Paul M Barr, Amanda F Cashen, Anthony R Mato, Avina K Singh, Michael P Mullane, Richard F Little, Harry P Erba, Richard M Stone, Mark R Litzow, Martin Tallman, Neil E Kay
Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial. Blood 140 (2) (2022)
Benjamin J Lee, Shawn P Griffin, Jean Doh, Alexandre Chan, Susan M O'Brien, Deepa Jeyakumar, Stefan O Ciurea, Pamela S Becker, Piyanuch Kongtim
CD19-directed immunotherapy use in KMT2A-rearranged acute leukemia: A case report and literature review of increased lymphoid to myeloid lineage switch. American journal of hematology 97 (12) (2022)
Benjamin J Lee, Jean Doh, Alexandre Chan, Deepa Jeyakumar, Susan M O'Brien
Increased incidence of Pegaspargase-induced hypertriglyceridemia and associated pancreatitis observed in the Hispanic adult patient population. Leukemia & lymphoma 63 (12) (2022)
Susan M O'Brien, John C Byrd, Peter Hillmen, Steven Coutre, Jennifer R Brown, Paul M Barr, Jacqueline C Barrientos, Stephen Devereux, Tadeusz Robak, Nishitha M Reddy, Thomas J Kipps, Alessandra Tedeschi, Florence Cymbalista, Paolo Ghia, Stephen Chang, Joi Ninomoto, Danelle F James, Jan A Burger
Outcomes with ibrutinib by line of therapy and post-ibrutinib discontinuation in patients with chronic lymphocytic leukemia: Phase 3 analysis. American journal of hematology 94 (5) (2019)
Elias J Jabbour, Anjali S Advani, Matthias Stelljes, Wendy Stock, Michaela Liedtke, Nicola Gökbuget, Giovanni Martinelli, Susan M O'Brien, Jane Liang White, Tao Wang, M Luisa Paccagnella, Barbara Sleight, Erik Vandendries, Daniel J DeAngelo, Hagop M Kantarjian
Prognostic implications of cytogenetics in adults with acute lymphoblastic leukemia treated with inotuzumab ozogamicin. American journal of hematology 94 (4) (2019)
Musa Ylimaz, Hagop M Kantarjian, Xuemei Wang, Joseph D Khoury, Farhad Ravandi, Jeffrey Jorgensen, Nicholas James Short, Sanam Loghavi, Jorge E Cortes, Guillermo Garcia-Manero, Tapan Mahendra Kadia, Koji Sasaki, Marina Konopleva, Koichi Takahashi, William Wierda, Nitin Jain, Srdan Verstovsek, Zeev Estrov, Prithviraj Bose, Sherry Pierce, Rebecca Garris, Susan M O'Brien, Elias J Jabbour
The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival. American journal of hematology 95 (2) (2019)
Tahla Munir, Jennifer R Brown, Susan M O'Brien, Jacqueline C Barrientos, Paul M Barr, Nishitha M Reddy, Steven Coutre, Constantine S Tam, Stephen P Mulligan, Ulrich Jaeger, Thomas J Kipps, Carol Moreno, Marco Montillo, Jan A Burger, John C Byrd, Peter Hillmen, Sandra Dai, Anita Szoke, James P Dean, Jennifer A Woyach
Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma. American journal of hematology 94 (12) (2019)
Susan M O'Brien, Manish Patel, Brad S Kahl, Steven M Horwitz, Francine M Foss, Pierluigi Porcu, Jeffrey Jones, Jan Burger, Nitin Jain, Kerstin Allen, Kerrie Faia, Mark Douglas, Howard M Stern, Jennifer Sweeney, Patrick Kelly, Virginia Kelly, Ian Flinn
Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study. American journal of hematology 93 (11) (2018)
Elias J Jabbour, Johannes Düll, Musa Ylimaz, Joseph D Khoury, Farhad Ravandi, Nitin Jain, Hermann Einsele, Guillermo Garcia-Manero, Marina Konopleva, Nicholas James Short, Philip A Thompson, William Wierda, Naval G Daver, Jorge Cortes, Susan M O'Brien, Hagop M Kantarjian, Max S Topp
Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression. American journal of hematology 93 (3) (2017)